Contact

All Stories

  1. Reasons for retraction of clinical research articles in PubMed indexed medical journals from 2012 to 2022

    Article • Indian Journal of Medical Ethics, October 2024, Forum for Medical Ethics Society

    Dr Miteshkumar Rajaram Maurya

  2. Safety analysis of all active risk evaluation & mitigation strategy for U.S. FDA approved drugs – An Indian perspective

    Article • The Indian Journal of Medical Research, August 2024, Scientific Scholar

    Dr Miteshkumar Rajaram Maurya

  3. A Case Report of Cefixime, Paracetamol, and Nimesulide Induced Toxic Epidermal Necrolysis in a Woman with Dengue Infection without any Other Associated Comorbidities

    Article • Current Drug Safety, May 2024, Bentham Science Publishers

    Dr Miteshkumar Rajaram Maurya

  4. An audit of prescribing pattern of anti-epileptic drugs with its effect on therapeutic drug levels and seizure control at a tertiary care public hospital

    Article • Ghana Medical Journal, September 2023, African Journals Online (AJOL)

    Dr Miteshkumar Rajaram Maurya

  5. Adherence to Consolidated Health Economic Evaluation Reporting Standards guidelines for published pharmacoeconomic studies in PubMed-indexed medical journals over a year (2021–2022)

    Article • Perspectives in Clinical Research, April 2023, Medknow

    Dr Miteshkumar Rajaram Maurya

  6. Efficacy and safety of AP-Bio®(KalmCold®) in participants with uncomplicated upper respiratory tract viral infection (common cold) - A phase III, double-blind, parallel group, randomized placebo-controlled trial

    Article • Complementary Therapies in Medicine, February 2023, Elsevier

    Dr Miteshkumar Rajaram Maurya

  7. A Comprehensive Review of the Impact of the Renin Angiotensin System in the Liver, Lung, Infectious Diseases and Cancers

    Article • January 2023, Springer Science + Business Media

    Dr Miteshkumar Rajaram Maurya

  8. Emerging Pharmacological Targets for Treatment of Dry Age-related Macular Degeneration and Geographical Atrophy

    Article • Journal of Exploratory Research in Pharmacology, December 2022, Xia & He Publishing

    Dr Miteshkumar Rajaram Maurya

  9. Public Awareness and Perception about Drug Safety in the Population Residing in Western India - A Questionnaire Based Cross Sectional Survey.

    Article • Biomedical & Pharmacology Journal, December 2022, Oriental Scientific Publishing Company

    Dr Miteshkumar Rajaram Maurya

  10. Drug-Induced Severe Cutaneous Adverse Reactions, Diagnostics and Management

    Article • November 2022, IntechOpen

    Dr Miteshkumar Rajaram Maurya

  11. Melanocortin receptors: emerging targets for the treatment of pigmentation, inflammation, stress, weight disorders and sexual dysfunction

    Article • Current Drug Targets, November 2022, Bentham Science Publishers

    Dr Miteshkumar Rajaram Maurya

  12. A Systematic Review and Meta-Analysis of the Safety of Hydroxychloroquine in a Randomized Controlled Trial and Observational Studies

    Article • Current Reviews in Clinical and Experimental Pharmacology, November 2022, Bentham Science Publishers

    Dr Urmila M Thatte, Dr Miteshkumar Rajaram Maurya

  13. Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in Ind...

    Article • Vaccine X, September 2022, Elsevier

    Dr Miteshkumar Rajaram Maurya

  14. Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis

    Article • International Journal of Clinical Practice, July 2022, Hindawi Publishing Corporation

    Dr Miteshkumar Rajaram Maurya

  15. Impact of disease-modifying therapies on MRI outcomes in patients with relapsing -remitting multiple sclerosis: A systematic review and network meta-analysis

    Article • Multiple Sclerosis and Related Disorders, May 2022, Elsevier

    Dr Miteshkumar Rajaram Maurya

  16. A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients

    Article • Current Drug Safety, May 2022, Bentham Science Publishers

    Dr Miteshkumar Rajaram Maurya

  17. Impact of educational intervention on the knowledge, attitude and practice of pharmacovigilance among nurses at a tertiary care public hospital

    Article • Current Drug Safety, April 2022, Bentham Science Publishers

    Dr Miteshkumar Rajaram Maurya

  18. Prognosis of Severe Acute Flares of Chronic Hepatitis B

    Article • Exploratory Research and Hypothesis in Medicine, February 2022, Xia & He Publishing

    Dr Miteshkumar Rajaram Maurya

  19. A comprehensive evaluation of the safety of ipilimumab, nivolumab and their combination therapy: A systematic review and network meta-analysis

    Article • Journal of Oncology Pharmacy Practice, February 2022, SAGE Publications

    Dr Miteshkumar Rajaram Maurya

  20. Cobra envenomation in an elderly female mimicking brain death- A case report

    Article • Journal of Family Medicine and Primary Care, January 2022, Medknow

    Dr Miteshkumar Rajaram Maurya

  21. Evaluation of genetic polymorphism of CYP3A5 in normal healthy participants from western India - A cross-sectional study

    Article • Indian Journal of Pharmacology, January 2022, Medknow

    Dr Miteshkumar Rajaram Maurya

  22. Withdrawal: “Efficacy and safety of liraglutide 3.0 mg in obese diabetic and non‐diabetic patients—A systematic review and meta‐analysis of randomised controlled trials” Mahanjit Konwar, Renju Ravi, Miteshkumar Maurya, Debdipta Bose, Sanjeet kumar Jaiswal

    Article • International Journal of Clinical Practice, November 2021, Hindawi Publishing Corporation

    Dr Miteshkumar Rajaram Maurya

  23. A case report of Arnold Chiari type 1 malformation in acromesomelic dwarf infant

    Article • Pan African Medical Journal, January 2021, Pan African Medical Journal

    Dr Miteshkumar Rajaram Maurya

  24. An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

    Article • Perspectives in Clinical Research, January 2021, Medknow

    Dr Miteshkumar Rajaram Maurya

  25. A literature review of consent declines and consent withdrawals in randomized controlled trials conducted during the COVID-19 pandemic

    Article • Journal of Postgraduate Medicine, January 2021, Medknow

    Dr Miteshkumar Rajaram Maurya

  26. An audit of questions asked by participants during the informed consent process for regulatory studies at a tertiary referral centre – An analysis of consent narratives

    Article • Clinical Ethics, September 2020, SAGE Publications

    Dr Miteshkumar Rajaram Maurya

  27. Knowledge, attitude and practice of needle stick injury and post exposure prophylaxis in undergraduate medical students

    Article • International Journal of Basic & Clinical Pharmacology, June 2018, Medip Academy

    Dr Miteshkumar Rajaram Maurya

  28. Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center

    Article • Perspectives in Clinical Research, January 2018, Medknow

    Dr Miteshkumar Rajaram Maurya

  29. Current scenario and distribution of NABL Accreditated laboratories in India

    Article • Journal of pharmacology & clinical research, September 2017, Juniper Publishers

    Dr Miteshkumar Rajaram Maurya

  30. Evaluation of nephroprotective effect of Bryonia lacinosa on streptozotocin induced diabetic nephropathy in rats

    Article • International Journal of Basic & Clinical Pharmacology, April 2017, Medip Academy

    Dr Miteshkumar Rajaram Maurya

  31. Assessment of clinical trials registered at clinical trial registry of India over past decade: an audit

    Article • International Journal of Clinical Trials, October 2016, Medip Academy

    Dr Miteshkumar Rajaram Maurya

  32. An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India

    Article • Perspectives in Clinical Research, January 2016, Medknow

    Dr Miteshkumar Rajaram Maurya